See every side of every news story
Published loading...Updated

Innocan Pharma earnings benefit from its beauty products

Summary by newsbudz.com
Innocan Pharma Corporation (CSE: INNO) (OTC: INNPF) reported its audited financial results for the year ending December 31, 2024, after the markets closed on March 31. Fourth-quarter earnings Innocan reported revenues of $5.4 million in the fourth quarter of 2024 versus $4.8 million in the fourth quarter of 2023. However, earnings fell... Please login to read all 385 words.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

newsbudz.com broke the news in on Wednesday, April 2, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.